Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein

OBJECTIVE:To determine the frequency of central venous catheter-induced thrombosis of the axillary vein. DESIGN:Prospective, controlled study. SETTING:Tertiary care university center. PATIENTS:Sixty patients in a medical-surgical intensive care unit who required central venous catheterization via th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 1999-12, Vol.27 (12), p.2626-2629
Hauptverfasser: Martin, Claude, Viviand, Xavier, Saux, Pierre, Gouin, François
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVE:To determine the frequency of central venous catheter-induced thrombosis of the axillary vein. DESIGN:Prospective, controlled study. SETTING:Tertiary care university center. PATIENTS:Sixty patients in a medical-surgical intensive care unit who required central venous catheterization via the axillary vein. INTERVENTIONS:Single-lumen, silicone elastomer or polyurethane catheters were inserted for a mean duration of 14.7± 7.4 days (range, 4-33 days). On catheter removal, bilateral upper-extremity phlebographic examination was performed in each patient. The incidence of deep vein thrombosis in catheterized arms was compared with that in uncatheterized arms. MEASUREMENTS AND MAIN RESULTS:Of the 60 patients who underwent axillary vein cannulation, one patient had clinical signs of arm vein thrombosis, but no patient had clinical sign of pulmonary embolism. There were 35 patients (58.3%) who developed positive phlebographic examinations homolateral to the catheter. Fibrin sleeves that developed around the catheters were observed in 28 patients (47%). Five patients (8.3%) had phlebographic signs of partial axillary vein thrombosisnonobstructive clots adherent to the vessel wall and/or the catheter. Two patients (3.3%) had phlebographic signs of complete axillary vein thrombosis. No thrombosis was observed in patients with catheterizations lasting ≤6 days, two cases were observed for duration of 7-14 days, and five cases were observed for duration of ≥15 days (p < .01). In the seven patients with axillary vein thrombosis, the vessel was cannulated with fewer than three puncture attempts, and the mean duration for catheter insertion (10 ± 2.5 min) was not different from that of patients with no axillary vein thrombosis (14 ± 9 min). CONCLUSIONS:Based on the data from the present study, we conclude that axillary vein catheterization is associated with a 11.6% frequency of upper-extremity deep vein thrombosis. This rate of vein thrombosis is similar to that observed after internal jugular or subclavian vein cannulation. Given the acceptable rate of this clinically important complication, axillary vein cannulation offers an attractive alternative site for catheter insertion to the internal jugular or subclavian vein in the critically ill. Because thrombosis is rare or absent in catheterizations lasting
ISSN:0090-3493
1530-0293
DOI:10.1097/00003246-199912000-00004